87 related articles for article (PubMed ID: 9053855)
1. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation.
Bartholomew C; Kilbey A; Clark AM; Walker M
Oncogene; 1997 Feb; 14(5):569-77. PubMed ID: 9053855
[TBL] [Abstract][Full Text] [Related]
2. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts.
Kilbey A; Bartholomew C
Oncogene; 1998 Apr; 16(17):2287-91. PubMed ID: 9619838
[TBL] [Abstract][Full Text] [Related]
3. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.
Kurokawa M; Ogawa S; Tanaka T; Mitani K; Yazaki Y; Witte ON; Hirai H
Oncogene; 1995 Sep; 11(5):833-40. PubMed ID: 7675444
[TBL] [Abstract][Full Text] [Related]
4. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
Mitani K
Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
[TBL] [Abstract][Full Text] [Related]
8. The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.
Matsugi T; Kreider BL; Delwel R; Cleveland JL; Askew DS; Ihle JN
Oncogene; 1995 Jul; 11(1):191-8. PubMed ID: 7624127
[TBL] [Abstract][Full Text] [Related]
9. EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC.
Morishita K; Suzukawa K; Taki T; Ihle JN; Yokota J
Oncogene; 1995 May; 10(10):1961-7. PubMed ID: 7761097
[TBL] [Abstract][Full Text] [Related]
10. The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG.
Funabiki T; Kreider BL; Ihle JN
Oncogene; 1994 Jun; 9(6):1575-81. PubMed ID: 8183551
[TBL] [Abstract][Full Text] [Related]
11. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3.
Kurokawa M; Mitani K; Irie K; Matsuyama T; Takahashi T; Chiba S; Yazaki Y; Matsumoto K; Hirai H
Nature; 1998 Jul; 394(6688):92-6. PubMed ID: 9665135
[TBL] [Abstract][Full Text] [Related]
12. Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells.
Bartholomew C; Clark AM
Oncogene; 1994 Mar; 9(3):939-42. PubMed ID: 8108138
[TBL] [Abstract][Full Text] [Related]
13. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.
McGilvray R; Walker M; Bartholomew C
FEBS J; 2007 Aug; 274(15):3960-71. PubMed ID: 17635584
[TBL] [Abstract][Full Text] [Related]
14. Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP.
Nitta E; Izutsu K; Yamaguchi Y; Imai Y; Ogawa S; Chiba S; Kurokawa M; Hirai H
Oncogene; 2005 Sep; 24(40):6165-73. PubMed ID: 15897867
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of a Zap1 zinc-responsive domain provides insights into metalloregulatory transcriptional repression in Saccharomyces cerevisiae.
Wang Z; Feng LS; Matskevich V; Venkataraman K; Parasuram P; Laity JH
J Mol Biol; 2006 Apr; 357(4):1167-83. PubMed ID: 16483601
[TBL] [Abstract][Full Text] [Related]
16. Association of specific DNA binding and transcriptional repression with the transforming and myogenic activities of c-Ski.
Nicol R; Zheng G; Sutrave P; Foster DN; Stavnezer E
Cell Growth Differ; 1999 Apr; 10(4):243-54. PubMed ID: 10319994
[TBL] [Abstract][Full Text] [Related]
17. The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death.
Kurokawa M; Mitani K; Yamagata T; Takahashi T; Izutsu K; Ogawa S; Moriguchi T; Nishida E; Yazaki Y; Hirai H
EMBO J; 2000 Jun; 19(12):2958-68. PubMed ID: 10856240
[TBL] [Abstract][Full Text] [Related]
18. A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110.
Cohen SB; Nicol R; Stavnezer E
Oncogene; 1998 Nov; 17(19):2505-13. PubMed ID: 9824161
[TBL] [Abstract][Full Text] [Related]
19. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts.
Morishita K; Parganas E; Douglass EC; Ihle JN
Oncogene; 1990 Jul; 5(7):963-71. PubMed ID: 2115646
[TBL] [Abstract][Full Text] [Related]
20. Biological activity of mammalian transcriptional repressors.
Thiel G; Lietz M; Bach K; Guethlein L; Cibelli G
Biol Chem; 2001 Jun; 382(6):891-902. PubMed ID: 11501753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
